Name: Development of a non-toxic cancer drug that disrupts oncogenic heat shock protein A/client protein interactions
Start: 2010-05-06T13:00:00+02:00
End: 2010-05-06T14:00:00+02:00

Suspended seminars

to be announced
Dr. Dagmara Sokołowska, Faculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, Kraków, Poland
January 27, 2010, 13:00 - 14:00
to be announced
Prof. Bronisław Marciniak, Wielkopolska Centre for Advanced Technologies, Poznań, Poland
March 25, 2010, 13:00 - 14:00
to be announced
Prof. Henri Jaffrès, Université Paris-Saclay CNRS Thales, France
April 29, 2010, 13:00 - 14:00
Development of a non-toxic cancer drug that disrupts oncogenic heat shock protein A/client protein interactions
Prof. Doris Benbrook, University of Oklahoma Health Sciences Center, Oklahoma, USA
May 6, 2010, 13:00 - 14:00

to be announced
Prof. Peter van Dongen, Johannes-Gutenberg-Universität, Mainz, Germany
June 23, 2030, 13:00 - 14:00

View All Events

Suspended seminars

to be announced

to be announced

to be announced

Development of a non-toxic cancer drug that disrupts oncogenic heat shock protein A/client protein interactions

to be announced